JRSBRT Home • Issue Contents

Splenic oligometastasis: Report of a patient successfully treated with stereotactic body radiation therapy
Aditya Juloori, Shireen Parsai and Kevin Stephans

The use of SRS/SBRT has been extensively reported on for tumors of the lung, liver, pancreas, adrenal gland, brain, and spine. Tumor control and associated toxicities of treatment are well understood and the use of SBRT in these sites is well-accepted. Here we uniquely report a detailed case of SBRT to the spleen and demonstrate pre- and post-treatment imaging along with treatment planning implications. We demonstrate excellent local control at 4 year follow-up with no development of late toxicity.

Keywords: Spleen, stereotactic body radiation therapy, oligometastasis

Full Text (IP)
Purchase Article (PDF)